| Identification | Back Directory | [Name]
IVHD-valtrate | [CAS]
28325-56-6 | [Synonyms]
Valtrate HD
IVHD-valtrate
Isovaleroxyhydroxydidrovaltratum
Isovaleroxyhydroxydihydrovaltrate
Butanoic acid, 3-methyl-2-(3-methyl-1-oxobutoxy)-, [(1S,2'R,4aR,6S,7aS)-6-(acetyloxy)-4a,5,6,7a-tetrahydro-4a-hydroxy-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-4-yl]methyl ester | [Molecular Formula]
C27H40O11 | [MDL Number]
MFCD28100656 | [MOL File]
28325-56-6.mol | [Molecular Weight]
540.6 |
| Hazard Information | Back Directory | [Biological Activity]
IVHD-valtrate is an active Valeriana jatamansi derivative that inhibits human ovarian cancer cells in vitro and in vivo. It induces apoptosis of cancer cells and inhibits ovarian cancer cells from arresting in G2/M phase. It has the potential to be a new chemotherapeutic agent for human ovarian cancer research. | [in vitro]
IVHD-valtrate inhibits the growth and proliferation of the A2780 and OVCAR-3 ovarian cancer cell lines in a concentration-dependent manner. IVHD-valtrate results in a relatively low cytotoxicity to immortalized non-tumorigenic human ovarian surface epithelial cells (IOSE-144). | [target]
|
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|